Bain Capital Life Sciences Opportunities III, LP
CIK 1950105 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Bain Capital Life Sciences Opportunities III, LP.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 31, 2026 | N-PX | 0001193125-26-376882 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001193125-26-350332 |
| Aug 14, 2026 | 13F-NT | 0001193125-26-350483 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001193125-26-350333 |
| May 15, 2026 | 13F-NT | 0001193125-26-226953 |
| Feb 17, 2026 | 13F-NT | 0001193125-26-054828 |
| Feb 17, 2026 | SCHEDULE 13G/A | 0001193125-26-054806 |
| Nov 14, 2025 | SCHEDULE 13G/A | 0001193125-25-283095 |
| Nov 14, 2025 | 13F-NT | 0001193125-25-283101 |
| Aug 29, 2025 | N-PX | 0000950130-25-000097 |
| Aug 14, 2025 | 13F-NT | 0000950123-25-008313 |
| Aug 14, 2025 | SCHEDULE 13G/A | 0000950170-25-108821 |
| May 15, 2025 | 13F-NT | 0000950123-25-005463 |
| Feb 14, 2025 | 13F-NT | 0000950123-25-002314 |
| Feb 14, 2025 | SCHEDULE 13G/A | 0000950170-25-020412 |
| Nov 14, 2024 | SC 13G/A | 0001193125-24-258837 |
| Nov 14, 2024 | 13F-NT | 0000950123-24-011427 |
| Aug 30, 2024 | N-PX | 0001021408-24-006628 |
| Aug 22, 2024 | SC 13G | 0001193125-24-205483 |
| Aug 12, 2024 | 13F-NT | 0000950123-24-007843 |
| May 15, 2024 | 13F-NT | 0000950123-24-005489 |
| Apr 25, 2024 | SC 13G | 0001193125-24-114098 |
| Feb 14, 2024 | 4 | 0000950170-24-015358 |
| Feb 14, 2024 | SC 13G | 0001193125-24-036609 |
| Feb 13, 2024 | 13F-NT | 0000950123-24-001896 |